Dynavax Technologies
DVAX
$11.21
Share price
-1.67%
Change (1 day)
-13.24%
Change (1 year)
Categories
Dynavax Technologies (DVAX) - Net assets
Net assets on the balance sheet as of March 2024 : $0.61 B
According to Dynavax Technologies
's latest financial reports the company has $0.61 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Dynavax Technologies - Net assets on balance sheet (from 2003 to 2024)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $0.62 B | 7.07% |
| 2022-12-31 | $0.58 B | 161.28% |
| 2021-12-31 | $0.22 B | 278.88% |
| 2020-12-31 | $58.69 M | 608% |
| 2019-12-31 | $8.29 M | -86.85% |
| 2018-12-31 | $63.06 M | -68.4% |
| 2017-12-31 | $0.19 B | 123.71% |
| 2016-12-31 | $89.2 M | -52.32% |
| 2015-12-31 | $0.18 B | 86.18% |
| 2014-12-31 | $0.10 B | -46.06% |
| 2013-12-31 | $0.18 B | 62.24% |
| 2012-12-31 | $0.11 B | 14.96% |
| 2011-12-31 | $99.88 M | 91.67% |
| 2010-12-31 | $52.11 M | 717.3% |
| 2009-12-31 | $6.37 M | -60.53% |
| 2008-12-31 | $16.15 M | -58.71% |
| 2007-12-31 | $39.13 M | -50.51% |
| 2006-12-31 | $79.07 M | 6.33% |
| 2005-12-31 | $74.36 M | 24.2% |
| 2004-12-31 | $59.87 M | -204.68% |
| 2003-12-31 | $-57.2 M | 1.47% |
| 2002-12-31 | $-56.38 M | 63.79% |
| 2001-12-31 | $-34.42 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $92.55 B | 14,865.40% | 🇺🇸 USA |
 Amgen AMGN | $5.02 B | 711.99% | 🇺🇸 USA |
 Biogen BIIB | $15.21 B | 2,359.74% | 🇺🇸 USA |
 Gilead Sciences GILD | $17.45 B | 2,722.24% | 🇺🇸 USA |
 Merck MRK | $40.42 B | 6,436.02% | 🇺🇸 USA |
 AstraZeneca AZN | $37.50 B | 5,963.41% | 🇬🇧 UK |
 GlaxoSmithKline GSK | $16.71 B | 2,603.05% | 🇬🇧 UK |
 Agenus
AGEN | -$0.2 B | -130.77% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $7.54 B | 1,119.60% | 🇮🇱 Israel |